New hormone breast cancer treatment reduces risk of recurrence by 25%

According to research presented at the European Society for Medical Oncology's virtual conference (ESMO), a new hormonal breast cancer treatment which includes the substance abemaciclib may reduce recurrence by up to 25%.News Medical
Source: Society for Endocrinology - Category: Endocrinology Source Type: news